Skip to main content
. 2018 Aug 8;26(12):1732–1742. doi: 10.1038/s41431-018-0224-1

Table 3.

Definitions of SFMPP classification of actionable genes (classes 1 to 3) involved in cancer predisposition in adults

SFMPP classification
Class 1
Recommended to report findings to the prescribing physician and to the patient
Class 2
Data from the literature and/or level of evidence insufficient to allow the development of guidelines
Class 3
Not recommended to report to the patient